These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Quinoxaline Moiety: A Potential Scaffold against Montana M; Montero V; Khoumeri O; Vanelle P Molecules; 2021 Aug; 26(16):. PubMed ID: 34443334 [No Abstract] [Full Text] [Related]
7. New 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents. Ancizu S; Moreno E; Solano B; Villar R; Burguete A; Torres E; Pérez-Silanes S; Aldana I; Monge A Bioorg Med Chem; 2010 Apr; 18(7):2713-9. PubMed ID: 20233660 [TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis. Santivañez-Veliz M; Pérez-Silanes S; Torres E; Moreno-Viguri E Bioorg Med Chem Lett; 2016 May; 26(9):2188-93. PubMed ID: 27025343 [TBL] [Abstract][Full Text] [Related]
9. Anti-Mycobacterium tuberculosis agents derived from quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide. Ortega MA; Sainz Y; Montoya ME; Jaso A; Zarranz B; Aldana I; Monge A Arzneimittelforschung; 2002; 52(2):113-9. PubMed ID: 11878199 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives. Moreno E; Ancizu S; Pérez-Silanes S; Torres E; Aldana I; Monge A Eur J Med Chem; 2010 Oct; 45(10):4418-26. PubMed ID: 20656380 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, 3D-QSAR analysis and biological evaluation of quinoxaline 1,4-di-N-oxide derivatives as antituberculosis agents. Pan Y; Li P; Xie S; Tao Y; Chen D; Dai M; Hao H; Huang L; Wang Y; Wang L; Liu Z; Yuan Z Bioorg Med Chem Lett; 2016 Aug; 26(16):4146-53. PubMed ID: 27426298 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of new 2-acetyl and 2-benzoyl quinoxaline 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents. Jaso A; Zarranz B; Aldana I; Monge A Eur J Med Chem; 2003 Sep; 38(9):791-800. PubMed ID: 14561478 [TBL] [Abstract][Full Text] [Related]
13. Selective activity against Mycobacteriumtuberculosis of new quinoxaline 1,4-di-N-oxides. Vicente E; Pérez-Silanes S; Lima LM; Ancizu S; Burguete A; Solano B; Villar R; Aldana I; Monge A Bioorg Med Chem; 2009 Jan; 17(1):385-9. PubMed ID: 19058970 [TBL] [Abstract][Full Text] [Related]
14. [Prospects for development of new antituberculous drugs]. Tomioka H Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850 [TBL] [Abstract][Full Text] [Related]
15. Antimycobacterial activity of new quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives. Ortega MA; Montoya ME; Jaso A; Zarranz B; Tirapu I; Aldana I; Monge A Pharmazie; 2001 Mar; 56(3):205-7. PubMed ID: 11265583 [TBL] [Abstract][Full Text] [Related]
16. Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs. Ancizu S; Moreno E; Torres E; Burguete A; Pérez-Silanes S; Benítez D; Villar R; Solano B; Marín A; Aldana I; Cerecetto H; González M; Monge A Molecules; 2009 Jun; 14(6):2256-72. PubMed ID: 19553897 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives. Zarranz B; Jaso A; Aldana I; Monge A Bioorg Med Chem; 2003 May; 11(10):2149-56. PubMed ID: 12713824 [TBL] [Abstract][Full Text] [Related]
18. Quinoxaline 1,4-di-N-Oxide Derivatives: Are They Unselective or Selective Inhibitors? Rivera G Mini Rev Med Chem; 2022; 22(1):15-25. PubMed ID: 33573542 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents. Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612 [TBL] [Abstract][Full Text] [Related]
20. New quinoxaline 1,4-di-N-oxides for treatment of tuberculosis. Sainz Y; Montoya ME; Martínez-Crespo FJ; Ortega MA; López de Ceráin A; Monge A Arzneimittelforschung; 1999 Jan; 49(1):55-9. PubMed ID: 10028381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]